Nordea Investment Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-68,916
| Closed | -$4.01M | – | 996 |
|
|
2019
Q2 | $4.01M | Sell |
68,916
-3,540
| -5% | -$206K | 0.01% | 590 |
|
|
2019
Q1 | $5.08M | Buy |
72,456
+946
| +1% | +$66.3K | 0.01% | 568 |
|
|
2018
Q4 | $4.61M | Sell |
71,510
-7,618
| -10% | -$491K | 0.01% | 532 |
|
|
2018
Q3 | $5.56M | Buy |
79,128
+11,776
| +17% | +$827K | 0.01% | 523 |
|
|
2018
Q2 | $3.4M | Sell |
67,352
-28,458
| -30% | -$1.43M | 0.01% | 562 |
|
|
2018
Q1 | $3M | Buy |
95,810
+15,097
| +19% | +$472K | 0.01% | 607 |
|
|
2017
Q4 | $2.76M | Buy |
80,713
+11,901
| +17% | +$407K | 0.01% | 531 |
|
|
2017
Q3 | $2.21M | Buy |
68,812
+10,787
| +19% | +$346K | 0.01% | 634 |
|
|
2017
Q2 | $1.89M | Buy |
58,025
+4,418
| +8% | +$144K | ﹤0.01% | 651 |
|
|
2017
Q1 | $1.69M | Buy |
53,607
+11,970
| +29% | +$377K | ﹤0.01% | 604 |
|
|
2016
Q4 | $1.22M | Hold |
41,637
| – | – | ﹤0.01% | 676 |
|
|
2016
Q3 | $1.2M | Buy |
41,637
+17,579
| +73% | +$508K | ﹤0.01% | 596 |
|
|
2016
Q2 | $623K | Buy |
+24,058
| New | +$623K | ﹤0.01% | 677 |
|